David Zaccardelli - Aug 29, 2025 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
President and CEO, Director
Signature
/s/ Andrew Fisher, Attorney-in-fact for David Zaccardelli
Stock symbol
VRNA
Transactions as of
Aug 29, 2025
Transactions value $
$0
Form type
4
Date filed
9/3/2025, 04:32 PM
Previous filing
Aug 5, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ZACCARDELLI DAVID President and CEO, Director 3 MORE LONDON RIVERSIDE, LONDON, UNITED KINGDOM /s/ Andrew Fisher, Attorney-in-fact for David Zaccardelli 2025-09-03 0001627642

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Gift $0 -1.2M -8.97% $0.00 12.2M Aug 29, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Consists of (i) 2,375,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 296,875 ADSs); and (ii) 9,801,144 Ordinary Shares underlying 1,225,143 ADSs.